Fortis Healthcare share news, announcements and annual reports

NSE: FORTISBSE: 532843Healthcare ServicesMid Cap

Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 · Listed May 2007

₹768.15₹13.25 (1.76%)BSE ₹769.80

Share price at the NSE close on 30 Oct 2026. Previous close ₹754.90.

30 Oct: open ₹754.90, high ₹768.15, low ₹745.00

52-week range of traded prices to 30 Oct 2026

₹704.95Low, 23 Oct 2026₹1,057.45High, 30 Oct 2025

Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar

Market cap: ₹57,992 Cr156th largest listed
P/E: 55.34
P/B: 5.86
Dividend yield: 0.13%
ROE: 11.1%
ROCE: 12.7%
Debt to equity: 0.28
Volume, NSE: 14,56,10356.9% delivered

Fortis Healthcare board meetings

172 filed, newest first. Page 1 of 4.

Oct 2026
- 29 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Jul 2026
- 30 Jul · Board meeting
  To consider and approve the Un-audited financial results (standalone & Consolidated) for the quarter ended Jun 30, 2026
- 8 Jul · Board meeting
  Outcome of Board Meeting held on July 08, 2026 regarding re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer)
May 2026
- 15 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and recommendation of Final Dividend for the year ended March 31, 2026.
Feb 2026
- 13 Feb · Board meeting
  Board meeting held on February 13, 2026.
- 6 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025
Nov 2025
- 4 Nov · Board meeting
  To consider and approve the Un - Audited financial results for the period ended September 30, 2025
Jul 2025
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2025 and Alteration of rights of debenture holders/ matters affecting the rights and interests of debenture holders of the existing 1,55,000 (One lac and fifty-five thousand) listed, senior, secured, rated, redeemable Non-Convertible Debenture, each having a face value of INR 1,00,000/- (Indian Rupees One lac) and an aggregate value of up to INR 1550,00,00,000/- (Indian Rupees One Thousand Five Hundred and Fifty Crores only)
May 2025
- 8 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2025 and dividend
Feb 2025
- 7 Feb · Board meeting
  Outcome of Board Meeting held on February 07, 2025.
- 7 Feb · Board meeting
  Outcome of the Board meeting held on February 07, 2025.
Jan 2025
- 29 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024
Dec 2024
- 27 Dec · Board meeting
  Outcome of Board Meeting held on December 27, 2024.
- 27 Dec · Board meeting
  Outcome of the Board meeting held on December 27, 2024.
Nov 2024
- 8 Nov · Board meeting
  Outcome of Board Meeting held on November 08, 2024.
- 8 Nov · Board meeting
  Board meeting held on November 08, 2024.
Oct 2024
- 30 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024
- 9 Oct · Board meeting
  Board meeting held on October 09, 2024.
- 4 Oct · Board meeting
  To consider Fund Raising
Aug 2024
- 30 Aug · Board meeting
  Board meeting held on August 30, 2024.
- 27 Aug · Board meeting
  To consider Fund Raising
- 6 Aug · Board meeting
  Outcome of Board Meeting held on August 06, 2024.
- 6 Aug · Board meeting
  Board meeting held on August 06, 2024.
Jul 2024
- 30 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024
- 5 Jul · Board meeting
  Board meeting held on July 05, 2024.
May 2024
- 16 May · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, May 23, 2024, inter-alia, to: a) consider and approve audited financial results of the Company for the quarter and financial year ended March 31, 2024; and b) consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2024. Further, in continuation to our letter ref. FHL/SEC/2023-24 dated March 27, 2024 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 25, 2024.
Mar 2024
- 13 Mar · Board meeting
  Board meeting held on March 13, 2024.
- 1 Mar · Board meeting
  Outcome of Board Meeting held on March 01, 2024.
- 1 Mar · Board meeting
  Board meeting held on March 01, 2024.
Feb 2024
- 7 Feb · Board meeting
  Board meeting held on February 07, 2024.
Jan 2024
- 31 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2023
Nov 2023
- 10 Nov · Board meeting
  Board meeting held on November 10, 2023.
- 3 Nov · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2023.Further, in continuation to our letter ref. FHL/SEC/2023-24 dated September 29, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 12, 2023.
Aug 2023
- 4 Aug · Board meeting
  Board meeting held on August 04, 2023.
Jul 2023
- 28 Jul · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 4, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2023.Further, in continuation to our letter ref. FHL/SEC/2023-24 dated June 29, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 6, 2023.
May 2023
- 16 May · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, May 23, 2023, inter-alia, to:a) consider and approve audited financial results of the Company for the quarter and financial year ended March 31, 2023; andb) consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2023. Further, in continuation to our letter ref. FHL/SEC/2022-23 dated March 30, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 25, 2023.
Feb 2023
- 10 Feb · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 10, 2023, inter-alia, considered and approved the Standalone and Consolidated un-audited financial results of the Company for the quarter and period ended on December 31, 2022. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for the quarter and period ended on December 31, 2022. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed.
- 3 Feb · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter ended December 31, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated December 29, 2022 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 12, 2023.
Nov 2022
- 3 Nov · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 11, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated September 29, 2022 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 13, 2022.
Aug 2022
- 5 Aug · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 5, 2022, inter-alia, considered and approved the following:(i) Standalone and Consolidated un-audited financial results of the Company for the quarter ended on June 30, 2022. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for the quarter ended on June 30, 2022. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed.(ii) Amalgamation of Fortis Asia Healthcare Pte Limited ( FAHPL) and Fortis Healthcare International Pte Limited ( FHIPL), step-down wholly-owned subsidiaries of the Company.
Jul 2022
- 28 Jul · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 5, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2022.Further, in continuation to our letter ref. FHL/SEC/2022-23 dated June 29, 2022 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 7, 2022.This is for your information and record.
May 2022
- 25 May · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 25, 2022, inter-alia, considered and approved the following:(i) Audited Standalone and Consolidated Financial results of the Company for the quarter and financial year ended March 31, 2022. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with unmodified opinion.Further, a copy of the press release and investor presentation being issued in this regard is also enclosed.(ii) Re-appointment of Mr. Ravi Rajagopal, Ms. Suvalaxmi Chakraborty and Mr. Indrajit Banerjee as Independent Directors of the Company, subject to approval of the shareholders, for the second term of upto 5 years.
- 18 May · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, May 25, 2022 to, inter-alia, consider and approve audited financial results for the quarter and year ended March 31, 2022.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated March 30, 2022 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 27, 2022.
Feb 2022
- 11 Feb · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 11, 2022, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on December 31, 2021.Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on December 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed.The meeting commenced at 1200 Hours IST and concluded at 1910 Hours IST.This is for your information and records please.
- 4 Feb · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 11, 2022 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended December 31, 2021.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated December 30, 2021 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 13, 2022.This is for your information and record please.
Nov 2021
- 12 Nov · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 12, 2021, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on September 30, 2021.Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on September 30, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed.The meeting commenced at 1200 Hours IST and concluded at 1855 Hours IST.This is for your information and records please.
- 5 Nov · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 12, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2021.Further, in continuation to our letter ref. FHL/SEC/2021-22 dated September 29, 2021 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 14, 2021.This is for your information and record please.
Aug 2021
- 13 Aug · Board meeting
  Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 13, 2021, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on June 30, 2021 along with limited review report thereon. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on June 30, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 1100 Hours IST and concluded at 1740 Hours IST. This is for your information and records please.
- 6 Aug · Board meeting
  Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, August 13, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter ended June 30, 2021. Further, in continuation to our letter ref. FHL/SEC/2021-22 dated June 29, 2021 captioned Closure of Trading Window, it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till August 15, 2021. This is for your information and record please.
May 2021
- 29 May · Board meeting
  Board meeting held on May 29, 2021.

Fortis Healthcare board meetings

Oct 2026

Jul 2026

May 2026

Feb 2026

Nov 2025

Jul 2025

May 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Aug 2024

Jul 2024

May 2024

Mar 2024

Feb 2024

Jan 2024

Nov 2023

Aug 2023

Jul 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

May 2021